Zeneca Pharmaceuticals
Patent Owner
Stats
- 1 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 25, 2002 most recent publication
Details
- 1 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 165 Total Citation Count
- Dec 15, 1987 Earliest Filing
- 16 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6410539 Imidazole derivatives and their use as farnesyl protein transferase inhibitorsExpiredMar 24, 00Jun 25, 02[A61K, C07D]
2002/0058,665 Imidazole derivatives and their use as farnesyl protein transferase inhibitorsAbandonedSep 20, 01May 16, 02[A61K, C07D]
2002/0052,376 Imidazole derivatives and their use as farnesyl protein transferase inhibitorsAbandonedSep 20, 01May 02, 02[A61K, C07D]
2002/0040,002 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factorAbandonedMar 22, 01Apr 04, 02[A61K, C07D]
6342765 Imidazole derivatives and their use as farnesyl protein transferase inhibitorsExpiredMar 24, 00Jan 29, 02[A61K, C07D]
5965559 Aminoheterocyclic derivatives as antithrombotic or anticoagulantExpiredMar 26, 97Oct 12, 99[A61K, C07D]
5719139 9-oxo-1-azabicyclo?5.2.0!non-2,4-diene-2-carboxylic acid compounds as antibioticsExpiredJan 16, 96Feb 17, 98[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.